JACC Journals
@jaccjournals.bsky.social
3.3K followers 61 following 130 posts
Official account representing the ACC's 10 #JACCJournals 📚, one of the most widely read and most impactful CV journal programs in the world 🫀 | https://www.jacc.org/
Posts Media Videos Starter Packs
jaccjournals.bsky.social
Explore #JACCCardioOnc’s new expert content hub featuring reviews, primers, societal statements, & How To manuscripts. These provide practical guidance for diagnosing & managing clinical scenarios in cancer care & survivorship. https://bit.ly/46SMQMM

#CardioOnc #CardioSky #MedSky
jaccjournals.bsky.social
#DAPT after valve-in-valve #TAVI may be associated with a lower one-year incidence of stroke, while no significant difference was observed for other major ischemic and bleeding outcomes or for premature valve deterioration. https://bit.ly/46zU4Gx

#GISE46 #JACCINT #CardioSky
jaccjournals.bsky.social
We're seeking a visionary leader in CV research to serve as the next Editor-in-Chief of #JACCAdvances. Applicants should have an academic appointment, a strong scholarly record, leadership experience, & knowledge of open access publishing.

Apply: https://t.co/u69ewQHR6G
Reposted by JACC Journals
accintouch.bsky.social
🎥 Dr. Fred Kusumoto shares the importance of clinical guidance beyond traditional #ClinicalGuidelines, & shares takeaways from 🆕 expert consensus decision pathway on tricuspid regurgitation (TR).

📖 Read: https://bit.ly/4ncVbSp

#JACC #ACCClinicalDoc #CardioSky #vhdTR @jaccjournals.bsky.social
jaccjournals.bsky.social
New 2025 ACC scientific statement reviews the role of inflammation in #CVD, covering #atherosclerosis, #heartfailure & #pericarditis. It highlights residual risk, screening, management & new therapies.

Get the details in #JACC: https://bit.ly/46ORETq #CardioSky
jaccjournals.bsky.social
Selective in vitro enhancement of cardiac myosin motor function and myofilament force generation by danicamtiv prompted clinical evaluation. A short course of danicamtiv was generally well tolerated in participants with #DCM https://bit.ly/4mE3vcM

#HFSA2025 #JACC #cvGenetics @jimjanuzzi.bsky.social
jaccjournals.bsky.social
Acoramidis 📉 cumulative CV outcomes in #ATTRCM vs placebo, w/ numerical differences by month 1 & 📈 through month 30 (53 events avoided/100 pts). Nearly 1/4 of events occurred in the first 6 months, underscoring the need for timely Tx https://bit.ly/4gLv5DG

#HFSA2025 #JACC #CardioSky
jaccjournals.bsky.social
Between 2021-2025, relatively few AHFTC fellowship programs matched most applicants. Applicants prioritize markers of hospital reputation & #Hearttx volumes over regional disease burden or geographical considerations. https://bit.ly/4nHnWXP

#HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social
jaccjournals.bsky.social
📢 New in #JACC: ACC/AHA methodology statements on:
🔹 Core Principles & Development
🔹 Cost/Value (update)
🔹 FDA Processes

Together with Circulation, they provide the framework to keep guidelines rigorous, transparent & responsive.

🔗 Explore the statements: https://bit.ly/3IE4EDc #CardioSky #MedSky
jaccjournals.bsky.social
At #UNGA80, experts shared the 2023 #GBDstudy, tracking #CVD trends in 204 countries since 1990. Full insights: https://bit.ly/4pxeDe6

🗨️ Dr. Krumholz: “Data should be a compass, not a mirror. We must focus efforts where they’re needed most. AI can transform care.”

#JACC #NHLBI @ihmeuw.bsky.social
jaccjournals.bsky.social
New in #JACC: A cross-trial analysis of 3 cardiac amyloidosis #ATTRCM trials reveals time-dependent effects of modern disease-modifying therapies on mortality.

Get the details: www.jacc.org/doi/10.1016/...

#ATTRMeeting2025 #ATTR2025 #Amyloidosis #CardioSky
Reposted by JACC Journals
hmkyale.bsky.social
Quality measurement was once a breakthrough.
But today it’s too slow, too costly, and too disconnected from daily care.

It’s time to reinvent it.

🆕 My Editor’s Page in JACC: www.jacc.org/doi/epdf/10....

@jaccjournals.bsky.social @yalemed.bsky.social
Computable Quality
You have to enable JavaScript in your browser's settings in order to use the eReader.
www.jacc.org
jaccjournals.bsky.social
A new ECDP addressing "10 issues for the clinician in TR evaluation & management" focuses specifically on patients with secondary TR in the chronic setting & intended to serve as a bridge to a future update of ACC/AHA #VHD guideline. Get the details: https://bit.ly/4ngIbvd

#JACC #vhdTR #CardioSky
jaccjournals.bsky.social
Young adults with high remnant cholesterol face significantly increased CV risk, even with optimal LDL-C. Findings from a 4.3M nationwide cohort highlight remnant-C as a potent, age-sensitive risk factor needing early preventive strategies. https://bit.ly/46KV4aP

#JACC #ASCVD #cvLipids #ACCIntl
jaccjournals.bsky.social
Recanalization of radial artery occlusion using distal radial access (DRA) is a safe, effective and reproducible procedure among centers with DRA expertise, according to a study published in #JACCINT.

Get the details: www.jacc.org/doi/10.1016/...
jaccjournals.bsky.social
Seeking visionary leader in CV research to serve as the next Editor-in-Chief of #JACCAdvances. Applicants should have an academic appointment, strong scholarly record, leadership experience, and knowledge of open access publishing.

Apply by Oct 15, 2025: https://bit.ly/47OsBCa
jaccjournals.bsky.social
Don’t miss your chance to present your research on cardiology’s premier stage at #ACC26! Now accepting abstracts, complex clinical cases from FITs and physicians, and CV Team abstracts and cases.

Submit by 1 pm ET on Sept. 30 https://bit.ly/4gmTC1C #CardioSky #CardioEd
jaccjournals.bsky.social
A patient-facing app prototype showed strong comprehension, accurate risk perception & behavioral intention, highlighting its potential to empower patients with actionable health insights. https://bit.ly/429B1A3

#JACCAdvances #HRX2025 #CIED #MachineLearning #HeartFailure #CardioSky
jaccjournals.bsky.social
In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ESCCongress, such as ALONE-AF, ODYSSEY-HCM, BaxHTN, & more!

📽️: https://bit.ly/4naa5Ze

#JACC #WCCardio #CardioSky #MedSky @accintouch.bsky.social
ACC Cardiology Hour from ESC 2025
YouTube video by American College of Cardiology
youtu.be
Reposted by JACC Journals
accintouch.bsky.social
❤️ Heart Failure in focus at #ESCCongress. #JACCHF Editor-in-Chief Dr. Biykem Bozkurt highlights key science from Hot Line 2.

📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
jaccjournals.bsky.social
In persistent #AFib, cryoballoon (CB) ablation was as effective as radiofrequency. Adding posterior wall isolation using CB ablation didn’t improve outcomes, so routine use isn’t supported. https://bit.ly/4n661cf

#JACCCEP #ESCCongress #WCCardio #epAblation #CardioSky #MedSky
jaccjournals.bsky.social
In this pooled analysis of 2 phase 3 clinical trials, obicetrapib treatment was associated with a reduction in coronary events, evident beyond 6 months of treatment. https://bit.ly/47ljrwK

#JACC #ESCCongress #WCCardio #CVD #MACE #cvLipids
jaccjournals.bsky.social
ENVAD-HF, a prospective RCT in stable HM3 #LVAD recipients, shows angiotensin–neprilysin inhibition is safe and well-tolerated, paving the way for trials of HF therapies in this population. https://bit.ly/47fJRQn

#JACCHF #ESCCongress #WCCardio #LVAD #HeartFailure #CardioSky